NYSE:PSTG
Everpure, Inc.
PSTG develops and sells advanced water purification systems for residential and industrial applications worldwide.
Key Metrics
Investment Thesis
Bull Case
Investors may favor PSTG due to the dramatic rebound in net income during 2025 and a resilient operating cash flow generation that supports aggressive capital return programs like share buybacks. The company's dominant position in niche industrial fluid processing segments offers stable, recurring revenue streams less susceptible to consumer economic downturns. Strong balance sheet liquidity with over $723M in cash equivalents provides flexibility for strategic acquisitions or R&D investments in emerging water technologies.
Bear Case
The bear case centers on the company's elevated working capital requirements, evidenced by current assets ($2.57B) significantly outpacing current liabilities ($1.60B), which ties up substantial capital in receivables relative to payables. Recent heavy investments in marketable securities and other investing activities totaling nearly $1B suggest potential distress or a shift toward speculative asset management rather than organic growth. Persistent high operating expenses, particularly marketing at $1.02B, combined with a large retained earnings deficit of -$1.37B, indicate underlying structural cost inefficiencies that could hinder future margin expansion.
About Everpure, Inc.
Everpure, Inc. (PSTG) designs and manufactures high-efficiency water treatment systems serving residential, commercial, and industrial markets globally. The company leverages its proprietary filtration technologies to provide solutions for drinking water, wastewater, and fluid processing across diverse sectors. With a diversified revenue stream spanning North America, Europe, Asia, and Latin America, PSTG addresses critical demand for clean water infrastructure.
Analysis
Management Discussion
Everpure reported a robust recovery in 2025 with revenue climbing to $3.17B and net income surging to $106.7M, reversing a two-year trend of declining profitability where net income dropped from $73.1M in 2023 to $61.3M in 2024. Despite substantial cash outflows from investing (-$218.2M) and financing activities (-$509.8M), likely driven by share repurchases of $374.0M, operating cash flow remained strong at $753.6M, indicating healthy core business liquidity.
Industry Overview
The global water treatment industry is experiencing sustained growth driven by increasing environmental regulations and the urgent need for clean water in emerging markets. Technological advancements in nanofiltration and reverse osmosis are expanding the addressable market beyond traditional municipal applications into high-value industrial processes. Competition is intensifying among established players like Everpure and new entrants offering lower-cost alternatives, forcing companies to innovate rapidly to maintain market share.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | $2.75B | $2.83B | $3.17B |
| Cost of Revenue | $855.8M | $809.4M | $955.5M |
| Gross Profit | $1.90B | $2.02B | $2.21B |
| Operating Expenses | $1.81B | $1.97B | $2.13B |
| Operating Income | $83.5M | $53.6M | $85.3M |
| R&D | $692.5M | $736.8M | $804.4M |
| G&A | $238.0M | $252.2M | $286.2M |
| Marketing | $883.6M | $945.0M | $1.02B |
| Stock-Based Comp | $327.6M | $331.4M | $421.3M |
| D&A | $87.0M | $112.6M | $114.5M |
| Amortization | $16.5M | $16.2M | $15.7M |
| Other OpEx | $0 | $33.6M | $15.9M |
| Non-Operating Income | $8.3M | $37.0M | $62.6M |
| Interest Expense | $4.7M | $7.5M | — |
| Interest Income | — | — | $76.0M |
| Pre-Tax Income | $91.8M | $90.6M | $147.8M |
| Income Tax | $18.7M | $29.3M | $41.1M |
| Continuing Ops | $73.1M | $61.3M | $106.7M |
| Discontinued Ops | $0 | $0 | $0 |
| Net Income | $73.1M | $61.3M | $106.7M |
| Minority Interest | $0 | $0 | $0 |
| Net to Common | $73.1M | $61.3M | $106.7M |
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Current Assets | $2.47B | $2.50B | $2.57B |
| Cash & Equivalents | $580.9M | $702.5M | $723.6M |
| Accounts Receivable | $612.5M | $662.2M | $680.9M |
| Inventory | $50.2M | $42.7M | $42.8M |
| Prepaid Expenses | $161.4M | $173.4M | $222.5M |
| Other Current Assets | $1.07B | $917.3M | $897.5M |
| Long-Term Assets | $1.07B | $1.16B | $1.40B |
| PP&E (Net) | $272.4M | $352.6M | $461.7M |
| Goodwill | $361.4M | $361.4M | $361.4M |
| Operating Leases | $158.9M | $129.9M | $146.7M |
| Other LT Assets | $275.8M | $313.7M | $426.9M |
| Total Assets | $3.54B | $3.66B | $3.96B |
| Current Liabilities | $1.75B | $1.37B | $1.60B |
| Accounts Payable | $67.1M | $82.8M | $112.4M |
| Current Debt | $574.5M | $0 | $100.0M |
| Current Leases | $33.7M | $44.7M | $43.5M |
| Deferred Revenue | $718.1M | $852.2M | $953.8M |
| Other Current Liab | $356.4M | $386.0M | $386.8M |
| Long-Term Liabilities | $852.4M | $1.02B | $1.06B |
| Long-Term Debt | $0 | $100.0M | $0 |
| LT Operating Leases | $142.5M | $123.2M | $137.3M |
| Other LT Liab | $42.4M | $54.5M | $82.2M |
| Total Liabilities | $2.60B | $2.39B | $2.66B |
| Shareholders' Equity | $941.2M | $1.27B | $1.31B |
| Retained Earnings | $-1.54B | $-1.48B | $-1.37B |
| AOCI | $-15.5M | $-3.8M | $954.0K |
| Total L&E | $3.54B | $3.66B | $3.96B |
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Net Income (CFO) | $73.1M | $61.3M | $106.7M |
| Non-Cash Adjustments | $282.5M | $325.5M | $318.2M |
| Working Capital Changes | $411.6M | $290.9M | $328.6M |
| Cash from Operations | $767.2M | $677.7M | $753.6M |
| Capital Expenditures | $158.1M | $195.2M | $226.7M |
| Cash from Investing | $-221.4M | $3.2M | $-218.2M |
| Share Buybacks | $219.1M | $135.8M | $374.0M |
| Cash from Financing | $-431.2M | $-560.2M | $-509.8M |
| FX Effect | $0 | $0 | $0 |
| Net Change in Cash | $114.7M | $120.7M | $25.6M |
| Beginning Cash | $476.7M | $591.4M | $712.1M |
| Ending Cash | $591.4M | $712.1M | $737.8M |
Frequently Asked Questions
How does Everpure, Inc. make money?
The company's financials reflect four primary revenue drivers: residential filtration products (under-sink and whole-house systems), commercial water treatment solutions for industries like food and beverage, wastewater recycling systems for municipalities and manufacturing, and fluid processing technologies used in pharmaceutical and chemical sectors.
What are the main risks for PSTG?
Significant concentration risk exists as accounts receivable ($680.9M) far exceed accounts payable ($112.4M), exposing the firm to potential liquidity strain if customers delay payments. The heavy reliance on capital expenditures ($226.7M) and other investing outflows ($916.7M) suggests aggressive expansion or M&A activity that could erode cash reserves if integration fails. Regulatory changes in water safety standards across different jurisdictions could invalidate existing product certifications, impacting sales. Volatility in raw material costs for manufacturing filtration membranes could compress gross margins.
What is PSTG's competitive advantage?
PSTG holds a strong patent portfolio protecting its proprietary membrane and filtration designs, creating a technical moat against generic competitors. The company benefits from high customer switching costs due to the specialized engineering required for industrial fluid processing applications. Additionally, its global manufacturing footprint and established distribution networks provide cost and logistics advantages in international markets.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.